Neonatal sepsis: the potential for immunotherapy.
There is tremendous potential for immunotherapy of neonatal sepsis, considering the continued high mortality of the disease. Current studies, particularly of intravenous immunoglobulin, have had encouraging outcomes. However, much more data need to be accumulated before clinical application.
Baley
J E
JE
Department of Pediatrics, Rainbow Babies and Children's Hospital, Cleveland, Ohio.
D001424:Bacterial Infections / Q000628:therapy*; D001803:Blood Transfusion / Q000379:methods; D005078:Exchange Transfusion, Whole Blood / Q000379:methods; D005353:Fibronectins / Q000627:therapeutic use; D006098:Granulocytes / Q000637:transplantation; D006801:Humans; D007116:Immunization, Passive / Q000379:methods; D007167:Immunotherapy / Q000379:methods*; D007231:Infant, Newborn
D005353:Fibronectins